Control Bionics’ assistive communication tools are now compatible with Apple devices, opening up myriad opportunities Nyrada plans a phase IIa cardioprotection trial Clinuvel scores a (grudging) ...

Control Bionics secures deal with Tobii Dynavox, global leader with augmentative and alternative communication solutions Tobii Dynavox will evaluate Control Bionics’ (ASX:CBL) NeuroNode for a ...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring ...

Control Bionics Ltd. (AU:CBL) has released an update. Control Bionics is revolutionizing communication for individuals with complex needs by introducing a range of AI-powered speech-generating devices ...

Revenue: AU$6.14m (up 15% from FY 2024). Net loss: AU$6.11m (loss widened by 3.3% from FY 2024). AU$0.023 loss per share. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% ...

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Control Bionics Ltd has successfully ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Control Bionics Limited revealed that on 19 October 2026, it issued 1,044,087 fully paid ordinary shares. The notice, signed ...